John K Bakewell is Director of Neuronetics, Inc.. Currently has a direct ownership of 114,352 shares of STIM, which is worth approximately $124,643. The most recent transaction as insider was on May 25, 2023, when has been sold 36,364 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 114K
0% 3M change
0% 12M change
Total Value Held $124,643

JOHN K BAKEWELL Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 25 2023
BUY
Grant, award, or other acquisition
-
36,364 Added 24.13%
114,352 Common Stock
May 24 2023
SELL
Open market or private sale
$38,880 $2.7 p/Share
14,400 Reduced 15.59%
77,988 Common Stock
May 26 2022
BUY
Grant, award, or other acquisition
-
38,910 Added 29.63%
92,388 Common Stock
May 27 2021
BUY
Grant, award, or other acquisition
-
7,137 Added 12.62%
49,428 Common Stock

Also insider at

TMCI
TREACE MEDICAL CONCEPTS, INC. Healthcare
XTNT
Xtant Medical Holdings, Inc. Healthcare
JKB

John K Bakewell

Director
Belgrade, MT

Track Institutional and Insider Activities on STIM

Follow Neuronetics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STIM shares.

Notify only if

Insider Trading

Get notified when an Neuronetics, Inc. insider buys or sells STIM shares.

Notify only if

News

Receive news related to Neuronetics, Inc.

Track Activities on STIM